First Trust Amex Biotech Index Fund FBT
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Net expense ratio
- 0.55%
- Net assets
- $2.8B
- Holdings
- 32
- 12-month distribution yield
- Unavailable
- Asset class
- Equity
First Trust Amex Biotech Index Fund (FBT) is an exchange-traded fund listed on NYSE Arca in the United States, issued by First Trust. Its category is Equity · Global (equity). Its last price was US$271.77 on 20 Oct 2026. Its net expense ratio is 0.55% a year, from its prospectus dated 1 May 2026. It reported net assets of US$2.81 billion as of 30 Jun 2026. Its latest holdings report lists 32 holdings as of 30 Jun 2026. No distributions are recorded for it over the last 12 months.
Fees
- Total annual operating expenses (gross)
- 0.55%
- Net, after fee waivers or reimbursements
- 0.55%
- Management fee
- 0.40%
- Prospectus date
- 1 May 2026
- Filed with the SEC
- 30 Apr 2026
Size and reporting
- Net assets
- $2,812,691,023
- Total assets
- $2,814,651,373
- Holdings as of
- 30 Jun 2026
- Report made public
- 21 Aug 2026 (52 days after the month end)
Top holdings
Largest 25 of 32 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | CORCEPT THERAPEUTICS INC CORCEPT THERAPEUTICS INC COM | US2183521028 | 5.60% | $157.5M | Equity (common) | United States | USD |
| 2 | NEOGENOMICS INC NEOGENOMICS INC COM NEW | US64049M2098 | 5.12% | $144.0M | Equity (common) | United States | USD |
| 3 | VERACYTE INC VERACYTE INC COM | US92337F1075 | 5.10% | $143.4M | Equity (common) | United States | USD |
| 4 | BRUKER CORP BRUKER CORP COM | US1167941087 | 4.32% | $121.5M | Equity (common) | United States | USD |
| 5 | ALKERMES PLC ALKERMES PLC SHS | IE00B56GVS15 | 4.24% | $119.2M | Equity (common) | Ireland | USD |
| 6 | ILLUMINA INC ILLUMINA INC COM | US4523271090 | 3.92% | $110.4M | Equity (common) | United States | USD |
| 7 | KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC COM | US5011471027 | 3.87% | $108.9M | Equity (common) | United States | USD |
| 8 | NATERA INC NATERA INC COM | US6323071042 | 3.79% | $106.7M | Equity (common) | United States | USD |
| 9 | AXSOME THERAPEUTICS INC AXSOME THERAPEUTICS INC COM | US05464T1043 | 3.71% | $104.3M | Equity (common) | United States | USD |
| 10 | NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC COM | US64125C1099 | 3.53% | $99.2M | Equity (common) | United States | USD |
| 11 | BIO-TECHNE CORP BIO-TECHNE CORP COM | US09073M1045 | 3.43% | $96.5M | Equity (common) | United States | USD |
| 12 | ARROWHEAD PHARMACEUTICALS INC ARROWHEAD PHARMACEUTICALS INC COM | US04280A1007 | 3.38% | $95.0M | Equity (common) | United States | USD |
| 13 | BIOGEN INC BIOGEN INC COM | US09062X1037 | 3.37% | $94.8M | Equity (common) | United States | USD |
| 14 | EXELIXIS INC EXELIXIS INC COM | US30161Q1040 | 3.32% | $93.3M | Equity (common) | United States | USD |
| 15 | INCYTE CORP INCYTE CORP COM | US45337C1027 | 3.18% | $89.6M | Equity (common) | United States | USD |
| 16 | ARGENX SE ARGENX SE SPONSORED ADR | US04016X1019 | 3.13% | $88.1M | Equity (common) | Netherlands | USD |
| 17 | HALOZYME THERAPEUTICS INC HALOZYME THERAPEUTICS INC COM | US40637H1095 | 3.11% | $87.6M | Equity (common) | United States | USD |
| 18 | VERTEX PHARMACEUTICALS INC VERTEX PHARMACEUTICALS INC COM | US92532F1003 | 3.07% | $86.4M | Equity (common) | United States | USD |
| 19 | REPLIGEN CORP REPLIGEN CORP COM | US7599161095 | 3.07% | $86.2M | Equity (common) | United States | USD |
| 20 | BIOMARIN PHARMACEUTICAL INC BIOMARIN PHARMACEUTICAL INC COM | US09061G1013 | 2.83% | $79.6M | Equity (common) | United States | USD |
| 21 | AMGEN INC AMGEN INC COM | US0311621009 | 2.78% | $78.3M | Equity (common) | United States | USD |
| 22 | BIONTECH SE BIONTECH SE SPONSORED ADS | US09075V1026 | 2.63% | $73.9M | Equity (common) | Germany | USD |
| 23 | GENMAB A/S GENMAB A/S SPONSORED ADS | US3723032062 | 2.62% | $73.8M | Equity (common) | Denmark | USD |
| 24 | UNITED THERAPEUTICS CORP UNITED THERAPEUTICS CORP COM | US91307C1027 | 2.56% | $71.9M | Equity (common) | United States | USD |
| 25 | ALNYLAM PHARMACEUTICALS INC ALNYLAM PHARMACEUTICALS INC COM | US02043Q1076 | 2.52% | $70.9M | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 100.01% | |
| Short-term investment vehicles (cash funds) | 0.05% | |
| Repurchase agreements | <0.01% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 84.96% | |
| Ireland | 4.24% | |
| Netherlands | 3.13% | |
| Germany | 2.63% | |
| Denmark | 2.62% | |
| Switzerland | 2.48% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 100.06% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 78.94% | |
| Industrials | 4.32% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- Unavailable
- 12-month yield
- Unavailable
- Frequency
- None in 12 months
- Latest ex-date
- 13 Dec 2024
12-month yield = distributions per unit with an ex-date in the last 12 months ÷ latest price × 100. It is not shown because there were no distributions in the last 12 months.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (2 payments)
| Ex-date | Amount per unit |
|---|---|
| 13 Dec 2024 | $1.1730 |
| 30 Dec 2021 | $2.2140 |
Filings and sources
- Form N-PORT report for June 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000012478) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- FBT and VT Vanguard Total World Stock Index ETF
- FBT and SMH VanEck Semiconductor ETF
- FBT and SOXX iShares PHLX SOX Semiconductor Sector Index Fund
- FBT and CGDV Capital Group Dividend Value ETF